A subset analysis of the randomised , phase 3 , MDS-004 study to evaluate outcomes in patients with International Prognostic Scoring System ( IPSS ) - defined Low - / Intermediate ( Int ) -1 - risk myelodysplastic syndromes ( MDS ) with isolated del ( 5q ) .